ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Guotong Qiu
Matched on ORCID iD 0000-0003-3009-1532; OpenAlex author ID A5058153811. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 2 papers · 2021: 2 papers
Papers 4
- Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2021.04.007↗
- Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancr… Co-author DOI 10.12659/msm.931868↗
- Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System. Co-author DOI 10.1155/2020/9093729↗
- Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin. Co-author DOI 10.1186/s12885-020-07556-z↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hu Ren · 4 shared papers, 2020–2021 · strength 0.50
- Paper Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocar… DOI 10.12659/msm.931868↗
- Paper Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Gra… DOI 10.1155/2020/9093729↗
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Lipeng Zhang · 3 shared papers, 2020–2021 · strength 0.39
- Paper Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocar… DOI 10.12659/msm.931868↗
- Paper Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Gra… DOI 10.1155/2020/9093729↗
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Chengfeng Wang · 3 shared papers, 2020–2021 · strength 0.39
- Paper Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocar… DOI 10.12659/msm.931868↗
- Paper Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Gra… DOI 10.1155/2020/9093729↗
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Zongting Gu · 3 shared papers, 2020–2021 · strength 0.37
- Paper Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocar… DOI 10.12659/msm.931868↗
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Paper Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and mi… DOI 10.1186/s12885-020-07556-z↗
- Yongxing Du · 2 shared papers, 2021 · strength 0.26
- Paper Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocar… DOI 10.12659/msm.931868↗
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Jianwei Zhang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreat… DOI 10.1016/j.pan.2021.04.007↗
- Paper Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and mi… DOI 10.1186/s12885-020-07556-z↗
- Chaorui Wu · 1 shared paper, 2020 · strength 0.13
- Ke Xu · 1 shared paper, 2021 · strength 0.11
- Guang Li · 1 shared paper, 2021 · strength 0.11
- Jin Peng He · 1 shared paper, 2020 · strength 0.11
- Chengfeng Wang · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.